Track the Nanjing Leads Biolabs Co., Ltd. - B - H Shares stock price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Market capitalisation: €2.1bn. The latest transaction was reported on 6 August 2026 (Sale). Among the most active insiders: ZUO HONGGANG. Every trade is accessible without an account.
12
Insider Decl.
n/a
Thresholds
€156,645
6 ops.
Buy Volume
€2m
6 ops.
Sell Volume
20Σ signal
Buys €156,645€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,087 of 28,717 companies
10.4
score / 100
Value
13
Quality
8
FCF yld-5.9%
Earn yld-15%
EV/EBITDA41.5x
ROE-18%
Gross mgn4.8%
Net mgn-12%
Debt/EBITDA24.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
About Nanjing Leads Biolabs Co., Ltd. - B - H Shares
Nanjing Leads Biolabs Co., Ltd. is a company focused on the development of biopharmaceutical products. It specializes in research and production of innovative solutions for the healthcare sector.